Bristol Myers Squibb (BMY) Curent Deferred Tax Liability (2009 - 2012)

Bristol Myers Squibb (BMY) has 4 years of Curent Deferred Tax Liability data on file, last reported at -$10.0 million in Q4 2012.

• Curent Deferred Tax Liability for Q4 2012 came in at -$10.0 million, down 66.67% year-over-year; the trailing twelve-month figure through Dec 2012 was -$10.0 million (down 66.67% YoY), and the FY2012 annual result was -$10.0 million, down 66.67% from the prior year.
• Curent Deferred Tax Liability slipped to -$10.0 million in Q4 2012 per BMY's latest filing, from -$6.0 million in the prior quarter.
• Over five years, Curent Deferred Tax Liability peaked at $8.0 million in Q4 2009 and troughed at -$10.0 million in Q4 2012.
• A 4-year average of -$3.2 million and a median of -$5.5 million in 2010 frame the typical range for Curent Deferred Tax Liability.
• The sharpest annual moves came in 2010 and 2011: Curent Deferred Tax Liability plunged 162.5% in 2010, then dropped 20.0% in 2011.
• A 4-year view of Curent Deferred Tax Liability shows it stood at $8.0 million in 2009, then sank by 162.5% to -$5.0 million in 2010, then decreased by 20.0% to -$6.0 million in 2011, then sank by 66.67% to -$10.0 million in 2012.
• Business Quant data shows BMY's Curent Deferred Tax Liability at -$10.0 million in Q4 2012, -$6.0 million in Q4 2011, and -$5.0 million in Q4 2010.